Gaveriaux-Ruff, Claire <br/><br/>
Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.  [electronic resource] 

 -  Pain  Jun 2011 
 - 1238-1248 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6623 
<br/><br/><label>Standard No.: </label>10.1016/j.pain.2010.12.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics, Opioid--therapeutic use<br/>Analysis of Variance<br/>Animals<br/>Benzamides--therapeutic use<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Freund's Adjuvant--adverse effects<br/>Ganglia, Spinal--pathology<br/>Guanosine 5'-O-(3-Thiotriphosphate)--pharmacokinetics<br/>Inflammation--chemically induced<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>NAV1.8 Voltage-Gated Sodium Channel<br/>Nociceptors--drug effects<br/>Pain--etiology<br/>Pain Measurement--methods<br/>Piperazines--therapeutic use<br/>Protein Binding--drug effects<br/>Receptors, Opioid, delta--deficiency<br/>Sodium Channels--genetics<br/>Sulfur Isotopes--pharmacokinetics